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Abstract
Objective: Despite improved perioperative management, atrial fibrillation (AF) after coronary artery bypass grafting (CABG) remains a
relevant clinical problem, whose pathogenetic mechanisms remain incompletely explained. A reduced incidence of postoperative AF has
been described in CABG patients receiving IV tri-iodothyronine (T3). This study was designed to define the role of thyroid metabolism on
the genesis of postoperative AF. Methods and results: Free T3 (fT3), free thyroxine (fT4), and thyroid stimulating hormone were assayed at
admission in 107 consecutive patients undergoing isolated CABG surgery. Patients with thyroid disease or taking drugs known to interfere
with thyroid function were excluded. A preoperative rhythm other than sinus rhythm was considered an exclusion criterion. Thirty-three
patients (30.8%) had postoperative AF. An older age (P ¼ 0:03), no therapy with b-blockers (P ¼ 0:08), chronic obstructive pulmonary
disease (P ¼ 0:08), lower left ventricle ejection fraction (P ¼ 0:09) and lower fT3 concentration (P ¼ 0:001), were univariate predictors of
postoperative AF. On multivariate analysis, low fT3 concentration and lack of b-blocking therapy were independently related with the
development of postoperative AF (odds ratio, OR, 4.425; 95% confidence interval, CI, 1.745–11.235; P ¼ 0:001 and OR 3.107; 95% CI
1.087–8.875; P ¼ 0:03, respectively). Postoperative AF significantly prolonged postoperative hospital stay (P ¼ 0:002). Conclusions: Low
basal fT3 concentration can reliably predict the occurrence of postoperative AF in CABG patients.
q 2003 Elsevier B.V. All rights reserved.
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1. Introduction
Postoperative atrial fibrillation (AF) occurs in 30% to
40% of patients undergoing coronary artery bypass grafting
(CABG) [1,2], and is associated with higher surgical
morbidity and increased hospital costs [1,2]. Several studies
have sought to identify baseline predictors of AF, but only
increased age has been consistently associated with AF after
CABG [1–5].
In a prospective, double-blind, placebo-controlled trial,
Klemperer and coworkers demonstrated that IV triiodothyr-
onine (T3) can significantly reduce the incidence of
postoperative AF in CABG patients [6], but the proposed
mechanisms explaining this effect were mostly speculative.
In recent years, the cardiovascular effects of thyroid
hormone have been deeply investigated [7], and a strong
relationship between low circulating levels of T3 and
adverse prognosis of cardiac patients has been recently
established [8]. Furthermore, a direct action of T3 on the
calcium handling of human atrial cardiomyocytes has been
described [9], and altered calcium handling has been
indicated as one of the factors underlying the arrhythmo-
genic ionic remodeling of the atrial myocardium [10,11].
The present study was designed to prospectively evaluate
the influence of basal thyroid hormone concentration on the
risk of postoperative AF.
2. Methods
2.1. Patients
Thyroid function profile was evaluated at admission in
all patients undergoing isolated CABG at our institution
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from October the 1st, 2002, to March the 31st, 2003.
Patients with known thyroid disease, and patients taking
drugs known to interfere with thyroid function were
excluded. Patients with a basal rhythm other than normal
sinus rhythm, and patients with a history of paroxysmal AF
were not enrolled.
This study was approved by the Ethical Committee of the
‘G. Pasquinucci Hospital’ and of the ‘Institute of Clinical
Physiology’ of the Italian National Research Council.
Written informed consent was obtained from all patients.
2.2. Thyroid hormone sampling
A 5 ml blood sample was obtained from all patients at
admission. All samples were collected in serum separator
tubes and immediately centrifuged and analyzed. Free T3
(fT3), free thyroxine (fT4) and thyroid stimulating hormone
(TSH) were assayed on all samples with the AxSYMw
Microparticle Enzyme Immunoassay (MEIA, Abbott Lab-
oratories, Diagnostic Division, Rome, Italy). The reference
intervals for our laboratory were as follows: fT3 2.23–5.35
pmol/l, fT4 9.14–23.81 pmol/l, and TSH 0.47–4.64
mIU/ml.
2.3. Preoperative and postoperative medications
Preoperative medications, including b-blockers and
calcium channel blockers, were routinely omitted on the
day of surgery. When not contraindicated, preoperative
medications were again administered on the first post-
operative day.
2.4. Anesthetic technique and surgical management
The anesthetic technique and surgical management
employed in this series have been previously described
[12]. Total intravenous anesthesia with diazepam, fentanyl,
pancuronium and propofol, was used in all cases. The
decision to use or not cardiopulmonary bypass was left to
the operating surgeon, and was mostly based on the severity
and extension of disease of the target vessels. Cardiopul-
monary bypass (CPB) was conducted on moderate
hypothermia (348C), and myocardial protection was
achieved by using intermittent anterograde hyperkalemic
warm blood cardioplegia. The final goal of CABG surgery
was to obtain a complete myocardial revascularization.
2.5. Electrocardiographic (ECG) monitoring
Postoperatively, patients were routinely monitored for
the occurrence of arrhythmias by bedside monitors during
intensive care unit stay (ICU), and by telemetry after ICU
discharge. Automatic arrhythmia detection and printed strip
report were employed in all cases. The occurrence of AF
was confirmed by a complete, 12 lead ECG in all cases.
Only sustained episodes of postoperative AF, as previously
defined [3,4], and documented by 12 lead ECG, were
included in the analysis.
2.6. Statistical analysis
Continuous variables are expressed as mean ^ standard
deviation. Dichotomous variables are expressed as percen-
tages. The association of preoperative, intraoperative and
postoperative variables with the occurrence of postoperative
AF was investigated by the Fisher’s exact test (dichotomous
variables), or by the unpaired Student’s t-test (continuous
variables). Non-normally distributed continuous variables
were analyzed by the Mann–Whitney U-test. The tested
variables are listed and defined in the Appendix A. Factors
resulting significantly associated to the development of AF
were then included in a logistic multivariate regression
model to ascertain their independent role. Also factors for
which the univariate analysis gave a P value #0.1, or of
known biologic significance, but failing to meet the critical
a level, were included. Odds ratio (OR) and 95% confidence
interval (CI) were calculated. Receiver operating charac-
teristic (ROC) curves were calculated to single out the best
cutoff value of fT3 predicting postoperative AF. The
accuracy of the test was assessed measuring the area
under the ROC curve (AUC). The AUC was assessed by the
non-parametric method of DeLong and Clarke-Pearson
[13]. The non-symmetric 95% CI for AUC was computed
using the Bootstrap Percentile Method [14], with 1000
bootstrap replications. The statistical significance of differ-
ence of AUC from that of the ‘line of no information’ was
evaluated by Mann–Whitney U-statistic. A P value ,0.05
was considered significant. Statistical analysis was con-
ducted using SPSS software version 10.1 (SPSS Inc,
Chicago, IL).
3. Results
3.1. Patients population
One-hundred and seven patients were included. Mean
age was 67.2 ^ 9.9 years, and 77 patients (71.9%) were
male. Preoperatively, 66 (61.6%) patients were on b-
blockers. Sixty-seven patients (62.6%) had a previous acute
myocardial infarction (AMI), and 23 (21.4%) had a recent
AMI. Mean left ventricle ejection fraction (LVEF) was
53 ^ 10%, and nine patients (8.4%) had a LVEF #40%.
Most patients (74.7%) had three-vessels disease. Mean fT3
at admission was 3.3 ^ 0.7 pmol/l, mean fT4 was
14.1 ^ 2.6 pmol/l, and mean TSH was 1.9 ^ 1.6 mIU/ml.
Demographic data are depicted in Table 1.
3.2. Early outcome and complications
Two patients (1.8%) died, both for multiorgan failure,
on the 7th and 11th postoperative day, respectively. Both
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patients had chronic renal failure requiring dialysis, and
the first one had undergone emergency CABG for acute,
evolving myocardial infarction. This second patient
developed AF on postoperative day 2.
Four patients (3.7%) had myocardial ischemia post-
operatively. Two of these (1.8%) developed a perioperative
myocardial infarction (POMI). Twelve patients (11.2%)
needed inotropic support for $24 h. Other major post-
operative complications included major bleeding (4.6%),
severe low output syndrome (2.7%), acute respiratory
failure (7.4%), acute renal failure (5.6%), and cerebro-
vascular accident (0.9%). Postoperative complications
were not related to the occurrence of postoperative AF
(Table 1).
Mean postoperative ICU stay was 25.9 ^ 19.0 h. Mean
postoperative hospital stay was 8.0 ^ 3.0 days. Postopera-
tive AF significantly prolonged postoperative hospital stay
(Table 1).
3.3. Predictors of AF
Thirty-three (30.8%) patients developed AF during the
postoperative period, with a peak incidence during post-
operative day 2 (Fig. 1). An older age, and lower fT3 at
admission were significantly associated with postoperative
AF. Other factors included in the multivariate logistic
regression model included male sex, LVEF, left atrial size,
therapy with b-blockers, chronic obstructive pulmonary
disease (COPD), and use of CPB. Outcome variables
significantly related to postoperative AF were not included
in the multivariate logistic regression analysis, since they
were considered as a consequence, rather than as a possible
causative factor, of AF (Table 1).
The results of the multivariate logistic regression
analysis are depicted in Table 2. Low fT3 at admission
resulted to be the single, most important, independent
predictor of postoperative AF. Furthermore, therapy with b-
blockers was independently associated with a reduction of
the risk of postoperative AF.
According to the ROC curve analysis, the best threshold
value of fT3 for predicting the occurrence of postoperative
AF was 3.34 pmol/l (ROC area, 0.698; 95% CI 0.587–
0.785; P , 0:001, Fig. 2). This cutoff value showed a
sensitivity of 0.85 and a specificity of 0.51.
3.4. fT3 and b-blockers
Serum fT3 concentration was similar in patients
receiving and not receiving therapy with b-blockers
Table 1
Baseline, operative and postoperative characteristics of patients with and
without postoperative AF
Factor AF
(n ¼ 33)
Non-AF
(n ¼ 74)
P*
fT3 (pmol/l) 3.0 ^ 0.4 3.5 ^ 0.7 0.005**
fT4 (pmol/l) 14.2 ^ 2.9 14.0 ^ 2.4 0.76
TSH mIU/ml 2.2 ^ 1.9 1.8 ^ 1.4 0.24
Age, years 70.2 ^ 9.4 65.8 ^ 9.8 0.03**
Sex (male, %) 26 (78.8) 51 (68.9) 0.35**
Hypertension, n (%) 23 (69.7) 53 (71.6) 0.82
Diabetes, n (%) 11 (33.3) 20 (27.0) 0.50
Smokers, n (%) 16 (48.5) 46 (62.2) 0.20
Dyslipemia, n (%) 25 (75.7) 55 (74.3) 0.32
LVEF % 50.5 ^ 9.0 53.9 ^ 9.7 0.09**
Left atrial size (mm) 39.3 ^ 2.2 38.8 ^ 2.2 0.24**
Previous AMI, n (%) 19 (57.5) 48 (64.8) 0.52
Recent AMI, n (%) 8 (24.2) 15 (20.3) 0.62
3-vessels disease 26 (78.8) 53 (71.6) 0.34
b-blockers, n (%) 16 (48.5) 50 (67.6) 0.08**
Ca2þ channel blockers 18 (54.5) 31 (41.9) 0.29
COPD, n (%) 8 (24.2) 8 (10.8) 0.08**
Renal failure, n (%) 2 (6.1) 2 (2.7) 0.58
Non-elective surgery, n (%) 16 (48.4) 29 (39.2) 0.29
CPB, n (%) 24 (72.7) 64 (86.4) 0.10**
Operative time (min) 216.2 ^ 46.8 217.3 ^ 59.4 0.93
CPB time (min) 94.4 ^ 23.9 96.1 ^ 29.5 0.82
Cross clamp time (min) 56.0 ^ 13.5 53.8 ^ 14.5 0.59
Graft (n) 2.3 ^ 0.8 2.6 ^ 1.0 0.43
Complete revascularization, n (%) 30 (90.9) 67 (90.5) .0.99
POMI, n (%) – 2 (2.7) .0.99
Major bleeding, n (%) 2 (6.1) 3 (4.0) 0.64
Need for inotropes, n (%) 6 (18.2) 6 (8.1) 0.18
LOS, n (%) 2 (6.1) 1 (1.3) 0.23
Acute renal failure, n (%) 3 (9.1) 3 (4.1) 0.37
Acute respiratory failure, n (%) 5 (15.1) 3 (4.1) 0.10
ICU stay (h) 30.7 ^ 27.7 23.7 ^ 13.1 0.08
MAV (h) 9.2 ^ 4.3 7.9 ^ 3.7 0.10
Postoperative stay 9.4 ^ 4.5 7.4 ^ 1.8 0.002
See Appendix A for variables definition. LVEF, left ventricle ejection
fraction. AMI, acute myocardial infarction. COPD, chronic obstructive
pulmonary disease. CPB, cardiopulmonary bypass. POMI, perioperative
myocardial infarction. LOS, low output syndrome. ICU, intensive care unit.
MAV, mechanical assisted ventilation. *Fisher’s exact test, unpaired
Student’s t-test, Mann–Whitney U-test. **Factors included in the multi-
variate logistic regression model.
Fig. 1. Time of occurrence of AF.
Table 2
Predictors of postoperative AF
Variables C OR (95% CI) P
fT3 21.488 0.226 (0.089–0.573) 0.001
b-blockers (no) 1.134 3.107 (1.087–8.875) 0.03
Multivariate logistic regression analysis.
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(3.3 ^ 0.6 pmol/l and 3.3 ^ 0.8, respectively, P ¼ 0:79).
Of the 62 patients with serum fT3 ,3.34 pmol/l, 27
(43.5%) had postoperative AF. Considering only this
particular subgroup, AF occurred in 31.4% of patients
receiving b-blockers and in 59.2% of patients not
receiving b-blockers (P ¼ 0:03). Logistic regression
analysis confirmed this observation (OR: 3.174; 95% CI,
1.112–9.053; P ¼ 0:03). On the other hand, the protective
effect of b-blockers was negligible in patients with serum
fT3 .3.34 pmol/l (OR: 0.4; 95% CI, 0.042–3.788;
P ¼ 0:42).
4. Discussion
Low serum T3 is a common finding in patients with
heart disease, and recent evidence suggests that altered
thyroid metabolism may significantly worsen the prog-
nosis of cardiac patients [8]. The results of previous
research indicate that the administration of exogenous T3
has a favorable impact on the outcome of CABG patients
[15,16], and that it is associated with a reduced incidence
of postoperative AF [6]. Nevertheless, the evidence for a
negative role of low T3 on the postoperative course of
CABG patients is lacking [17]. Our data show that low
serum fT3 at admission is strongly predictive of post-
operative AF, and that a unit reduction of the fT3
concentration is associated with more than 4-fold increase
of postoperative AF risk.
4.1. Association between thyroid function
and postoperative AF
In light of the known association between chronic
hyperthyroidism and AF, the finding that low fT3 is
associated with an increased incidence of atrial fibrillation
after CABG may appear unexpected. Nonetheless, some
argument exists that could potentially explain the result of
our study.
Thyroid hormone actively participates to cardiomyocytes
calcium handling. In particular, it increases the expression
of the Ca2þ adenosine triphosphatase of the sarcoplasmic
reticulum (SERCA 2) [9,18]. Depressed SERCA 2
expression, as observed in T3-deprived human cardiomyo-
cytes in culture, results in a reduced Ca2þ load inside the
intracellular compartment [9], a figure similar to that
observed in arrhytmogenic ionic remodeling [10,11].
Furthermore, a reduction in L-type Ca2þ current (Ica) has
been described in the ventricular myocytes of hypothyroid
guinea pigs [19], and down regulation of L-type Ca2þ
current has been consistently reported in animal and human
models of AF [1,2,10,11]. T3 also exerts important effects
on the density ant the kinetics of other ionic currents flowing
during the action potential of cardiomyocytes [20].
According to these observations, normal thyroid hormone
availability should be considered as one of the factors
needed to maintain the normal electrophysiological proper-
ties of the atrium. Consequentially, low T3 could potentially
predispose to atrial arrythmias. The already mentioned
finding that the administration of exogenous T3 reduces the
incidence of AF in CABG patients [6] also seems to support
this hypothesis, especially if one considers that cardiac
surgery decreases the circulating levels of fT3 [12,21], thus
potentially augmenting the adverse effect of a lower basal
serum fT3 concentration.
4.2. Predictors of atrial fibrillation: limitations
of the study
Although the only factor consistently associated with the
occurrence of AF by previous literature is patients age,
several other baseline predictors of postoperative AF in
CABG patients have been identified by well-designed and
rigorous clinical trials [1–5]. Surprisingly, most of these
were not significant in our analysis.
Patients age had a significant effect at univariate analysis
(Table 1), but resulted non-significant at multivariate
logistic regression, although a trend in this direction was
observed (P ¼ 0:1). This was likely due to the fact that our
study was conducted on a relatively small number of
patients. A larger series would have probably evidenced the
effect of older age. Similar observations may be formulated
with regard to the effect of LVEF (P ¼ 0:09).
CPB has been reported to be the most important cause of
postoperative AF in CABG patients [4]. We found no
relationship between CPB and postoperative AF (Table 1),
but only 19 patients (17.6%) in our series underwent off-
pump CABG, and our results should be considered
inconclusive in this regard. Similarly, only nine patients
(8.4%) in our series had a LVEF #40%, and we can not
draw conclusions about the effect of depressed LV function.
Fig. 2. Receiver operating characteristic curve for the prediction of
postoperative AF. The rhomboid point shows the best predictive value of
fT3 (3.34 pmol/l). AUC ¼ 0.698; 95% CI ¼ 0.587–0.785. P , 0:001.
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Left atrial dilation increases the risk of AF in the general
population [11]. We found no relationship between left
atrial size and postoperative AF, and this result is consistent
with previous literature on postoperative AF in CABG
patients [3].
4.3. Clinical relevance of the present study
Despite increased knowledge of the mechanisms under-
lying the development of atrial arrythmias and despite the
improved anesthetic and surgical management of CABG
patients, postoperative AF remains a relevant clinical
problem, and the increasing number of proposed strategies
to prevent AF onset is testament to this [22].
On the other hand, the previous observation that T3
administration improves the outcome of cardiac surgery
mostly relied on a theoretical basis, and, apart from the
above mentioned results [6,15,16], a real clinical benefit
deriving from T3 supplementation has not been proven, at
least in adult patients undergoing CABG [17,23].
Our study demonstrates the existence of a strong,
previously unrecognized, relationship between preoperative
thyroid metabolism and the occurrence of postoperative AF.
According to our results, patients with a basal fT3
concentration ,3.34 pmol/l should be considered at higher
risk of postoperative AF, and should receive antiarrythmic
prophylaxis. Consequentially, thyroid function profile
evaluation should be recommended in patients scheduled
for CABG surgery.
The appreciation of the thyroid hormone role in the
regulation of the cardiovascular system function, and the
recognition of cardiac surgery as a possible cause of the so-
called ‘euthyroid sick syndrome’ [24], have led, in the past
decade, to the development of several protocols involving
perioperative T3 supplementation. Indeed, the results of the
two largest randomized, placebo-controlled trials on IV T3
administration in CABG patients [15,16] showed only
marginal in-hospital benefit. Our data, in conjunction with
the results of other investigations [6,8,9,15,16], are likely to
stimulate further research in this field. We are convinced
that careful selection of patients, based on preoperative
thyroid function profile assessment, will result in increased
statistical power, reduced consumption of hospital
resources, and, possibly, in increased clinical benefit for
the treated patients, with a marginal increase of the hospital
costs.
4.4. Conclusion
Low fT3 at admission is a strong independent risk factor
of postoperative AF after CABG. Therapy with b-blockers
is effective in reducing the risk of postoperative AF, and
should be employed in patients with basal fT3 ,3.34
pmol/l. Prospective double-blind, placebo-controlled trials,
enrolling only patients with low basal fT3, are needed to
define the efficacy of T3 supplementation in preventing the
onset of postoperative AF after CABG.
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Appendix A
Variables employed in the univariate analysis (Fisher’s exact test,
unpaired Student’s t-test, Mann–Whitney U-test): fT3 concentration, fT4
concentration, TSH concentration, age, sex, arterial hypertension, diabetes,
smoking history, dyslipidemia, LVEF, left atrial size, previous AMI, recent
AMI (#1 month prior to hospital admission), therapy with b-blockers,
therapy with calcium channel blockers, chronic obstructive pulmonary
disease (COPD, defined by a positive bronchospirometric test), chronic
renal failure (basal creatinine $2 mg/dl), surgical priority (elective versus
urgent), use of CPB, operative time, CPB time, aortic cross-clamp time,
number of grafts per patient, completeness of the revascularization, POMI
defined as the presence of two or more of the following criteria: enzymatic
elevation (CK-MB .10% of total CK or Troponine I .0.5 ng/ml), new Q
waves greater than 0.03 ms or a reduction in R waves greater than 25% in
two leads, and new akinetic segment(s) shown at echocardiogram),
postoperative bleeding (.800 ml/12 h), need for inotropes (dopamine or
dobutamine for $24 h), low output syndrome (requirement for more than
one of the above mentioned drugs or for adrenaline, noradrenaline,
enoximone, or IABP), acute renal failure (postoperative creatinine .2
mg/dl with a serum creatinine rise $0.7 mg/dl versus baseline), acute
respiratory failure (need of mechanical assisted ventilation (MAV) for more
than 24 h or the need of reintubation), ICU length of stay, MAV time, and
postoperative hospital stay.
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